Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD"
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD"
About this item
Full title
Author / Creator
Terpos, Evangelos , Ntanasis-Stathopoulos, Ioannis , Kastritis, Efstathios , Hatjiharissi, Evdoxia , Katodritou, Eirini , Eleutherakis-Papaiakovou, Evangelos , Verrou, Evgenia , Gavriatopoulou, Maria , Leonidakis, Alexandros , Manousou, Kyriaki , Delimpasi, Sosana , Malandrakis, Panagiotis , Kyrtsonis, Marie-Christine , Papaioannou, Maria , Symeonidis, Argiris and Dimopoulos, Meletios-Athanasios
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Biomarkers of bone turnover in serum are suggestive of bone dynamics during treatment in multiple myeloma (MM). We evaluated the role of daratumumab on bone remodeling among patients with relapsed/refractory MM in the prospective, open-label, phase 2 study REBUILD. Daratumumab was administered according to the approved indication. A total of 33 out...
Alternative Titles
Full title
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD"
Authors, Artists and Contributors
Author / Creator
Ntanasis-Stathopoulos, Ioannis
Kastritis, Efstathios
Hatjiharissi, Evdoxia
Katodritou, Eirini
Eleutherakis-Papaiakovou, Evangelos
Verrou, Evgenia
Gavriatopoulou, Maria
Leonidakis, Alexandros
Manousou, Kyriaki
Delimpasi, Sosana
Malandrakis, Panagiotis
Kyrtsonis, Marie-Christine
Papaioannou, Maria
Symeonidis, Argiris
Dimopoulos, Meletios-Athanasios
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9179322
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9179322
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers14112768
